ADIPOQ and breast carcinoma: Other results showed that adiponectin significantly decreased the proliferation of MDA-MB-231 and T47D [67,74], which are two human breast cancer cell lines, and the inhibitory role resulted from the induction of apoptosis coupled with the arrest of the cell cycle at the G0-G1 phase through the indirect suppression of cyclin D1 expression [67].